Yan-Hong Liu

Title: Yan-Hong Liu: Innovator in Medicinal Chemistry

Introduction

Yan-Hong Liu is a prominent inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that enhance cognitive functions. His work focuses on creating innovative solutions for improving awareness, concentration, and memory retention.

Latest Patents

Yan-Hong Liu holds a patent for "6-arylamino-5-cyano-4-pyrimidinones as PDE9A inhibitors." This invention relates to novel 6-arylamino-5-cyano-4-pyrimidinones of formula (I), methods for their production, and their use in producing medicaments aimed at enhancing cognitive abilities. The compounds demonstrate activity as PDE9 inhibitors, which are crucial for developing treatments that improve mental functions.

Career Highlights

Yan-Hong Liu is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to work on cutting-edge research and development projects that aim to address various health challenges. His expertise in medicinal chemistry has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Yan-Hong Liu has collaborated with notable colleagues, including Martin Hendrix and Lars Bärfacker. These collaborations have fostered an environment of innovation and have contributed to the advancement of research in medicinal chemistry.

Conclusion

Yan-Hong Liu's contributions to the field of medicinal chemistry, particularly through his patent on PDE9A inhibitors, highlight his commitment to improving cognitive health. His work at Boehringer Ingelheim International GmbH and collaborations with esteemed colleagues further emphasize his impact in the industry.